Key Concepts:
- ASX reporting season
- Earnings expectations
- US tariffs impact
- Consumer caution
- Resource equities decline
- Banking sector outlook
- Rate-sensitive stocks
- PE ratio
- Fundamentals vs. market momentum
- Wellness industry
- Longevity clinics
- Telehealth and prescription drugs
- R&D tax offsets
- Housing market in New Zealand
ASX Reporting Season and Earnings Expectations
The twice-yearly reporting season for ASX-listed companies is underway. Analysts anticipate soft company earnings due to Trump's tariff regime and consumer caution. Equity markets have reached all-time highs, but earnings expectations have been nudged down. The market seeks earnings growth to justify share prices. Profits across the ASX 200 index are expected to fall by about 2% this financial year, driven by a 20% profit fall in mining and energy companies. Rio Tinto's profits were impacted by weak iron ore prices, oversupply, and slowing demand from China. The Commonwealth Bank's performance is also in focus, with potential ripple effects if it disappoints. The banking space is expected to see no profit growth into FY26.
Impact of Economic Factors
Cost of living pressures and limited interest rate cuts have made consumers reluctant to spend. The consumer space is on the back foot, and the healthcare sector faces challenges. Analysts expect some good results from companies like West Farmers and JB Hi-Fi. The reporting season will reveal the impact of US tariffs on companies like Ensil and Breville. Labor costs, inflation, and the lack of a rate cut are dampening consumer sentiment. The outlook for the year ahead is expected to be more positive, potentially marking the bottom of Australian economic activity.
ASX Issues and Market Performance
The ASX faced a difficult week, with its virtual monopoly under threat and an embarrassing mistake involving TPG Telecom shares. ASIC is in the final stages of allowing another stock exchange, the US CBOE Group, to enter the Australian market. The ASX also flagged a $35 million hit from ASIC's ongoing inquiry. The ASX confused TPG Telecom with a similarly named private equity group. The share market pulled back from record levels, but the ASX 200 and All Ordinaries still gained around 1.7% each.
Market Analysis and Fundamentals
The ASX 200 hit a record this week, breaching 8,800 points. Rate-sensitive stocks, discretionary players like West Farmers and JB Hi-Fi, and gold stocks are driving the movement in equity markets. CBA is also adding significant points. The market is trading at a premium, and fundamentals have been put to one side. The PE ratio of the NASDAQ is in the 20s, while the S&P 500 is at the top end of 17 to 18, driven by tech. The market has been ignoring overbought sectors for a long period.
Tariffs and Pharmaceutical Companies
Tariffs are a big issue for investors, and pharmaceuticals are in the firing line from Donald Trump. Companies like CSL face an existential issue and must decide whether to invest in the US or deal with the current situation. CSL is the number one in blood plasma products and vaccines, with most of its manufacturing in the US.
Optus Data Breach and Payment Reforms
Singtel, Optus, and Optus Systems are being accused of failing to protect the personal information of 9.5 million Australians, facing a potential fine running into the tens of millions of dollars. The RBA's payment reforms to ban card searchcharges may reduce costs for consumers, but banking may get more expensive. Banks may hike card charges or reduce reward programs to recoup lost revenue. The RBA's proposal to cap interchange fees means banks will miss out on $900 million each year. Small businesses may have to increase prices if payment costs can't be passed on to customers. The banks want Apple and Google Pay to be included in the review.
ATO and R&D Tax Offsets
The ATO is challenging Ingams over its $50 million tax offset claims for research and development. The company says it will vigorously defend its position. More than $11 billion a year is on offer to encourage companies to spend money on research. R&D incentive disputes are tough, involving science, law, and accounting. Companies need to prove that there was no other way of doing what they did. Australia spends about 1.7% of its GDP on R&D, while many European countries spend more than 3%.
New Zealand Housing Market
New Zealand housing prices have crashed by around 20% from their peak. The market is well-balanced, with prices rising by about 1% in the first half of the year but going backwards in June and July. Interest rates in New Zealand have fallen, but there has been a marked increase in supply. Housing in New Zealand is expensive on the basis of international metrics. House prices were overvalued a few years ago but now look a bit undervalued. The supply response into the market has been more flexible, with easing in planning rules and increasing densification in cities like Oakland.
Wellness Industry and Longevity
The global wellness industry is worth $2.5 trillion. Tech entrepreneur Christian Sternson is one of the founders of Super Young, a Melbourne longevity clinic. Brian Johnson spends millions of dollars creating an anti-aging protocol. The evidence base for many alternative health practices is minimal. Eucalyptus launched a longevity app for men but pulled the pin soon after. The company's weight loss service allows customers to access prescription drugs like OMIC via a telehealth app. More than 100,000 people around the world bought weight loss drugs through the business. The model of online prescriptions has been criticized by the body representing general practitioners.
Synthesis/Conclusion:
The Australian business landscape is currently navigating a complex interplay of factors, including global economic uncertainties, domestic consumer behavior, and regulatory changes. The ASX reporting season is expected to reflect these challenges, with potential impacts on various sectors. Meanwhile, emerging trends like the growth of the wellness industry and evolving housing market dynamics in New Zealand present both opportunities and risks for businesses and consumers alike.
AI summaries can miss context or contain errors. Check important details against the original video.